The use of medicinal cosmetics in the complete treatment of rosacea
Keywords:medicinal cosmetics, rosacea, dermatosis, biologically active substances
AbstractThe aim of work is to carry out literature analysis about etiology and pathogenesis, classification and methods for rosacea correction, to conduct marketing research of the pharmaceutical market of medical cosmetics, to identify the main groups of biologically active substances in their composition.
Materials and methods. In the course of the research we analyzed the pharmaceutical market of Ukraine for the availability of pharmaceutical cosmetics (price policy of the manufacturer) and the composition of biologically active substances.Results. The medicinal cosmetic products (MCP) for the skin prone to couperose and rosacea are represented by the products of Ukraine and foreign manufacturers - namely, France, Canada, Poland and Russia. French anti-cure agents are represented by the following companies: Avene, La Roche, Ducray, Uriage, Lierac, Nuxe, Ukrainian – Stop Cuperoz, Polish - Clarena, Canada by Galderma and Russian – Cora.When reviewing the biologically active components of MCP presented in the market it is evident that they include a large number of extracts, vitamins, essential oils, vegetable oils, organic acids, as well as proprietary complexes. Predominantly, these substances are anti-inflammatory, venotonic, anti-edema, reduce vascular permeability and strengthen the walls of capillaries. Gel, lotions, tonics, emulsions, milk, creams and thermal water are selected as cosmetic forms.
Conclusions. On the basis of the literature analysis, the main causes of occurrence, pathogenesis of rosacea (couperose) and methods of its correction were established. Statistical and comparative methods were used in the research process. As a result of the research of the market of anticorrosion agents, it was established that MCP are represented by foreign manufacturers, the vast majority of which are French (75 %). 18.8 % of the data are made by manufacturers of Canada, Poland and Russia. Ukrainian MCP are represented by "PhytoBioTechnologies " – 6.25 %. As for dosage forms – creams prevail. There are also emulsions, tonics, milk, thermal water, masks, gels and lotions. There are groups of basic biologically active substances in the composition of MCP against couperose. Based on the research, the Ukrainian national market has the potential to introduce new medical forms, both national and foreign.
(2017) Rozatsea na oblychchi – pershi symptomy, stadii, prychyny ta mozhlyvi uskladnennia [Rosacea on the face - the first symptoms, stages, causes and possible complications]. Visnyk zdorovia. Retrieved from http://vashaibolit.com.ua/3439-rozacea-na-oblichch-persh-simptomi-stadyi-prichini-ta-mozhliv-uskladnennya.html. [in Ukrainian].
(2016) Rozatsea: prychyny, symptomy i likuvannia rozatsea na oblychchi [Rosacea: Causes, Symptoms and Treatment of Rosacea on the Face] Berezhit zdorovia. Retrieved from http://meduk.net.ua/archives/10077. [in Ukrainian].
Rozatsea [Rosacea]. Evromedprestizh. Retrieved from http://www.policlinica.ru/rozatsea.html. [in Russian].
O’lкhovskaya, A. B., Kobets, M. N., & Felonenko, L. S. (2011) Marketynhove doslidzhennіa vitchyznіanoho rynku likuvalnoi kosmetyky [The marketing researches to medical cosmetics in the the domestic market]. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 3(17), 63–67. [in Ukrainian].
How to Cite
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)